Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 50 composition records across product categories including Personal care, Food and drug.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of DIBASIC CALCIUM PHOSPHATE DIHYDRATE in our catalog (epa_cpdat).
Products
50
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 50 composition records across product categories including Personal care, Food and drug. EPA CPDat classifies this chemical for functional uses including Abrasive, Opacifer, oral care.
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 51 %w/w
US
FDA
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: ORAL; Dosage form: CAPSULE; Potency: 400 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 51 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2442 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 53 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 488.7 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 2834 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1036 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 953 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 258.45 mg
US
FDA
FDA NDC lists this ingredient in 3 active drug products and 3 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.